[
  {
    "ts": null,
    "headline": "Elevance Health Inc. stock outperforms competitors despite losses on the day",
    "summary": "Elevance Health Inc. stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=872325e1d0dab03cc559b42f43b6c6fb408b9fb0cdbc49d92ac216ea6b0c876a",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732034580,
      "headline": "Elevance Health Inc. stock outperforms competitors despite losses on the day",
      "id": 131510036,
      "image": "",
      "related": "ELV",
      "source": "MarketWatch",
      "summary": "Elevance Health Inc. stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=872325e1d0dab03cc559b42f43b6c6fb408b9fb0cdbc49d92ac216ea6b0c876a"
    }
  },
  {
    "ts": null,
    "headline": "Elevance Health price target lowered to $483 from $495 at Wells Fargo",
    "summary": "Wells Fargo analyst Stephen Baxter lowered the firm’s price target on Elevance Health (ELV) to $483 from $495 and keeps an Overweight rating on the shares as the firm updates Managed Care estimates post-election. All estimates assume the expiration of enhanced exchange subsidies for 2026, Wells notes. The firm believes Medicare Advantage risk/reward improves with Republicans, although areas of concern still exist. Published first on TheFly – the ultimate source for real-time, market-moving break",
    "url": "https://finnhub.io/api/news?id=15836196b7134c1021adc6b02d77f10cf4e22b6941ef58bef68a6350c8209ce5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732014929,
      "headline": "Elevance Health price target lowered to $483 from $495 at Wells Fargo",
      "id": 131470085,
      "image": "",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "Wells Fargo analyst Stephen Baxter lowered the firm’s price target on Elevance Health (ELV) to $483 from $495 and keeps an Overweight rating on the shares as the firm updates Managed Care estimates post-election. All estimates assume the expiration of enhanced exchange subsidies for 2026, Wells notes. The firm believes Medicare Advantage risk/reward improves with Republicans, although areas of concern still exist. Published first on TheFly – the ultimate source for real-time, market-moving break",
      "url": "https://finnhub.io/api/news?id=15836196b7134c1021adc6b02d77f10cf4e22b6941ef58bef68a6350c8209ce5"
    }
  }
]